234 related articles for article (PubMed ID: 22949885)
1. Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis.
Patel J; Balabanov R
Int J Mol Sci; 2012; 13(8):10647-10659. PubMed ID: 22949885
[TBL] [Abstract][Full Text] [Related]
2. Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
Loda E; Balabanov R
Rev Neurosci; 2012 Jan; 23(2):145-52. PubMed ID: 22499673
[TBL] [Abstract][Full Text] [Related]
3. Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases.
Stone S; Wu S; Jamison S; Durose W; Pallais JP; Lin W
Glia; 2018 Jul; 66(7):1331-1345. PubMed ID: 29436030
[TBL] [Abstract][Full Text] [Related]
4. Survival of oligodendrocytes in chronic relapsing experimental autoimmune encephalomyelitis.
Moore GR; Traugott U; Raine CS
J Neurol Sci; 1984 Aug; 65(2):137-45. PubMed ID: 6481396
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms Governing Oligodendrocyte Viability in Multiple Sclerosis and Its Animal Models.
Lei Z; Lin W
Cells; 2024 Jan; 13(2):. PubMed ID: 38247808
[TBL] [Abstract][Full Text] [Related]
6. Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination.
Rodriguez EG; Wegner C; Kreutzfeldt M; Neid K; Thal DR; Jürgens T; Brück W; Stadelmann C; Merkler D
Acta Neuropathol; 2014 Aug; 128(2):231-46. PubMed ID: 24563023
[TBL] [Abstract][Full Text] [Related]
7. NF-κB Activation Protects Oligodendrocytes against Inflammation.
Stone S; Jamison S; Yue Y; Durose W; Schmidt-Ullrich R; Lin W
J Neurosci; 2017 Sep; 37(38):9332-9344. PubMed ID: 28842413
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis.
Ren Z; Wang Y; Tao D; Liebenson D; Liggett T; Goswami R; Clarke R; Stefoski D; Balabanov R
J Neurosci; 2011 Jun; 31(23):8329-41. PubMed ID: 21653838
[TBL] [Abstract][Full Text] [Related]
9. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
[TBL] [Abstract][Full Text] [Related]
10. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
[TBL] [Abstract][Full Text] [Related]
11. The response of adult oligodendrocyte progenitors to demyelination in EAE.
Reynolds R; Cenci di Bello I; Dawson M; Levine J
Prog Brain Res; 2001; 132():165-74. PubMed ID: 11544985
[TBL] [Abstract][Full Text] [Related]
12. Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis.
Raine CS; Moore GR; Hintzen R; Traugott U
Lab Invest; 1988 Oct; 59(4):467-76. PubMed ID: 2459499
[TBL] [Abstract][Full Text] [Related]
13. Primary oligodendrocyte death does not elicit anti-CNS immunity.
Locatelli G; Wörtge S; Buch T; Ingold B; Frommer F; Sobottka B; Krüger M; Karram K; Bühlmann C; Bechmann I; Heppner FL; Waisman A; Becher B
Nat Neurosci; 2012 Feb; 15(4):543-50. PubMed ID: 22366759
[TBL] [Abstract][Full Text] [Related]
14. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage.
Lin W; Bailey SL; Ho H; Harding HP; Ron D; Miller SD; Popko B
J Clin Invest; 2007 Feb; 117(2):448-56. PubMed ID: 17273557
[TBL] [Abstract][Full Text] [Related]
15. ALCAM on human oligodendrocytes mediates CD4 T cell adhesion.
Jamann H; Desu HL; Cui QL; Halaweh A; Tastet O; Klement W; Zandee S; Pernin F; Mamane VH; Ouédraogo O; Daigneault A; Sidibé H; Millette F; Peelen E; Dhaeze T; Hoornaert C; Rébillard RM; Thai K; Grasmuck C; Vande Velde C; Prat A; Arbour N; Stratton JA; Antel J; Larochelle C
Brain; 2024 Jan; 147(1):147-162. PubMed ID: 37640028
[TBL] [Abstract][Full Text] [Related]
16. Glutamate excitotoxicity--a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis?
Werner P; Pitt D; Raine CS
J Neural Transm Suppl; 2000; (60):375-85. PubMed ID: 11205156
[TBL] [Abstract][Full Text] [Related]
17. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
18. Spatiotemporal distribution of fibrinogen in marmoset and human inflammatory demyelination.
Lee NJ; Ha SK; Sati P; Absinta M; Luciano NJ; Lefeuvre JA; Schindler MK; Leibovitch EC; Ryu JK; Petersen MA; Silva AC; Jacobson S; Akassoglou K; Reich DS
Brain; 2018 Jun; 141(6):1637-1649. PubMed ID: 29688408
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation.
Madsen PM; Pinto M; Patel S; McCarthy S; Gao H; Taherian M; Karmally S; Pereira CV; Dvoriantchikova G; Ivanov D; Tanaka KF; Moraes CT; Brambilla R
J Neurosci; 2017 Oct; 37(42):10185-10199. PubMed ID: 28931570
[TBL] [Abstract][Full Text] [Related]
20. Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE.
Yue Y; Stanojlovic M; Lin Y; Karsenty G; Lin W
J Neuroinflammation; 2019 Feb; 16(1):23. PubMed ID: 30709400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
